Open Access Research article

Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2

Meilang Xue1*, Kaitlin Shen1, Kelly McKelvey1, Juan Li1, Yee-Ka Agnes Chan1, Vicky Hatzis1, Lyn March2, Christopher B Little3, Michael Tonkin4 and Christopher J Jackson1

Author Affiliations

1 Sutton Arthritis Research Laboratories, The University of Sydney at Royal North Shore Hospital, Pacific Highway, St Leonards, NSW 2065, Australia

2 Department of Rheumatology, The University of Sydney at Royal North Shore Hospital, Pacific Highway, St Leonards, NSW 2065, Australia

3 Raymond Purves Research Laboratory, The University of Sydney at Royal North Shore Hospital, Pacific Highway, St Leonards, NSW 2065, Australia

4 Department of Surgery, Kolling Institute of Medical Research, The University of Sydney at Royal North Shore Hospital, Pacific Highway, St Leonards, NSW 2065, Australia

For all author emails, please log on.

Arthritis Research & Therapy 2014, 16:R44  doi:10.1186/ar4473

Published: 5 February 2014

Additional files

Additional file 1: Figure S1:

Protein C/activated protein C (PC/APC) expression and its effect on rheumatoid synovial fibroblast (RASF) viability.

Format: PPTX Size: 3.9MB Download file

Open Data